The Neuroprotective Effects of DPP-4 and SGLT2 Inhibitors in Type 2 Diabetes: Possible Mechanism for Halting Cognitive Deterioration

被引：0
|
作者：
Osman, Shams T. [1 ]
Hamdy, Noha A. [1 ]
El Feky, Amr Y. [2 ]
El-Khordagui, Labiba K. [1 ]
El-Yazbi, Ahmed F. [3 ]
机构：
[1] Alexandria Univ, Fac Pharm, Alexandria, Egypt
[2] Alexandria Univ, Fac Med, Alexandria, Egypt
[3] Alexandria Univ, Alexandria, Egypt
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2023年 / 385卷
关键词：
D O I：
10.1124/jpet.122.138010
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
256
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Where Does Combination Therapy With an SGLT2 Inhibitor Plus a DPP-4 Inhibitor Fit in the Management of Type 2 Diabetes?
    Abdul-Ghani, Muhammad
    DIABETES CARE, 2015, 38 (03) : 373 - 375
  • [42] Pharmacokinetic Characteristics and Clinical Efficacy of an SGLT2 Inhibitor Plus DPP-4 Inhibitor Combination Therapy in Type 2 Diabetes
    Scheen, Andre J.
    CLINICAL PHARMACOKINETICS, 2017, 56 (07) : 703 - 718
  • [43] Fractures with SGLT-2 vs DPP-4 inhibitors
    Reactions Weekly, 2019, 1778 (1) : 9 - 9
  • [44] The safety of DPP-4 inhibitor and SGLT2 inhibitor combination therapies
    Molina-Vega, Maria
    Munoz-Garach, Araceli
    Fernandez-Garcia, Jose C.
    Tinahones, Francisco J.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (08) : 815 - 824
  • [45] SGLT2 inhibitors in the treatment of type 2 diabetes
    Hasan, Farhad M.
    Alsahli, Mazen
    Gerich, John E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 104 (03) : 297 - 322
  • [46] SGLT2 inhibitors in the management of type 2 diabetes
    R. P. Monica Reddy
    Silvio E. Inzucchi
    Endocrine, 2016, 53 : 364 - 372
  • [47] SGLT2 inhibitors in the management of type 2 diabetes
    Reddy, R. P. Monica
    Inzucchi, Silvio E.
    ENDOCRINE, 2016, 53 (02) : 364 - 372
  • [48] Disparities in prescribing of sodium-glucose co-transporter-2 (SGLT2) inhibitors and DPP-4 inhibitors in people with Type 2 diabetes and chronic kidney disease (CKD)
    Shah, S.
    Whyte, M. B.
    McGovern, A.
    Van Vlymen, J. N.
    Hinton, W.
    Munro, N.
    de Lusignan, S.
    DIABETIC MEDICINE, 2018, 35 : 162 - 163
  • [49] SGLT2 Inhibitors in Type 2 Diabetes Mellitus
    Ferrannini, Giulia
    Savarese, Gianluigi
    Cosentino, Francesco
    HEART FAILURE CLINICS, 2022, 18 (04) : 551 - 559
  • [50] The Effects of DPP-4 Inhibitors on Plasma Catecholamines and Their Metabolites in Patients with Type 2 Diabetes
    Park, Ie Byung
    Lee, Daeho
    Lee, Kiyoung
    DIABETES, 2019, 68
12345